GI tract

Teduglutide listed on PBS for Short Bowel Syndrome

Patients with intestinal failure associated with Short Bowel Syndrome (SBS), will have access to PBS-subisdised teduglutide (Revestive) from 1 October. The medication, which improves the absorption of nutrients and fluid from the gut, is expected to be accessed by up to 70 patients per year who would otherwise face costs of up to $284,700 per ...

Already a member?

Login to keep reading.

© 2021 the limbic